HIV Cure Challenger CytoDyn Takes On The Gilead Sciences
July 03, 2020 at 12:10 PM EDT
CytoDyn Inc. announced in a Proactive Investors video a major advancement in HIV whose message that may have gotten buried due to a lengthy disclosure about a fake new article that was promulgated by short seller Citron Research.